These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 15054158

  • 41. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K, Merry P, Scott DG.
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [Abstract] [Full Text] [Related]

  • 42. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F, Alvarez L, Peris P, Guañabens N, Vidal-Sicart S, Monegal A, Pavía J, Ballesta AM, Muños-Gómez J, Herranz R.
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [Abstract] [Full Text] [Related]

  • 43. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
    Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM, John MR.
    Bone; 2009 Dec; 45(6):1053-8. PubMed ID: 19679211
    [Abstract] [Full Text] [Related]

  • 50. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA.
    J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
    [Abstract] [Full Text] [Related]

  • 51. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C.
    J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE, McCloskey EV, Dewar JA, Body JJ, Cameron DA, Harnett AN, Ruutu M, Purohit OP, Tähtelä R, Coleman RE.
    Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
    [Abstract] [Full Text] [Related]

  • 55. Biochemical markers of bone metabolism in growing thoroughbreds: a longitudinal study.
    Price JS, Jackson BF, Gray JA, Harris PA, Wright IM, Pfeiffer DU, Robins SP, Eastell R, Ricketts SW.
    Res Vet Sci; 2001 Aug; 71(1):37-44. PubMed ID: 11666146
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 58. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
    Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E.
    Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154
    [Abstract] [Full Text] [Related]

  • 59. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE, Bone HG, Caulfield MP, Kagan R, Buinewicz A, Chen E, Rosenberg E, Reitz RE.
    Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.